ExodusPoint Capital Management’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-42,000
| Closed | -$1.41M | – | 1945 |
|
|
2025
Q1 | $1.41M | Sell |
42,000
-26,884
| -39% | -$902K | 0.01% | 775 |
|
|
2024
Q4 | $2.7M | Sell |
68,884
-193,747
| -74% | -$7.59M | 0.02% | 561 |
|
|
2024
Q3 | $10.3M | Sell |
262,631
-94,547
| -26% | -$3.72M | 0.06% | 200 |
|
|
2024
Q2 | $13.9M | Buy |
357,178
+203,140
| +132% | +$7.92M | 0.1% | 158 |
|
|
2024
Q1 | $6.63M | Sell |
154,038
-11,229
| -7% | -$483K | 0.05% | 252 |
|
|
2023
Q4 | $7.61M | Sell |
165,267
-194,571
| -54% | -$8.96M | 0.05% | 221 |
|
|
2023
Q3 | $12.3M | Buy |
+359,838
| New | +$12.3M | 0.12% | 161 |
|
|
2023
Q2 | – | Sell |
-302,980
| Closed | -$10.8M | – | 2188 |
|
|
2023
Q1 | $10.8M | Buy |
+302,980
| New | +$10.8M | 0.09% | 202 |
|
|
2022
Q3 | – | Sell |
-31,332
| Closed | -$953K | – | 2287 |
|
|
2022
Q2 | $953K | Buy |
+31,332
| New | +$953K | 0.01% | 1056 |
|
|
2021
Q4 | – | Sell |
-11,866
| Closed | -$181K | – | 2594 |
|
|
2021
Q3 | $181K | Buy |
+11,866
| New | +$181K | ﹤0.01% | 1754 |
|
|
2020
Q3 | – | Sell |
-19,888
| Closed | -$249K | – | 2223 |
|
|
2020
Q2 | $249K | Buy |
+19,888
| New | +$249K | 0.01% | 1392 |
|